27 related articles for article (PubMed ID: 626996)
1. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
Lee SW; Lee TS; Hong DG; No JH; Park DC; Bae JM; Seong SJ; Shin SJ; Ju W; Lee KH; Lee YK; Cho H; Lee C; Paek J; Kim HJ; Lee JW; Kim JW; Bae DS
J Gynecol Oncol; 2017 Jan; 28(1):e12. PubMed ID: 27894165
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.
Makker V; Hensley ML; Zhou Q; Iasonos A; Aghajanian CA
Int J Gynecol Cancer; 2013 Jun; 23(5):929-34. PubMed ID: 23598889
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.
Vale CL; Tierney J; Bull SJ; Symonds PR
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003915. PubMed ID: 22895938
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for endometrial cancer after hysterectomy.
Johnson N; Bryant A; Miles T; Hogberg T; Cornes P
Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD003175. PubMed ID: 21975736
[TBL] [Abstract][Full Text] [Related]
5. Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.
Brown J; Smith JA; Ramondetta LM; Sood AK; Ramirez PT; Coleman RL; Levenback CF; Munsell MF; Jung M; Wolf JK
Cancer; 2010 Nov; 116(21):4973-9. PubMed ID: 20665499
[TBL] [Abstract][Full Text] [Related]
6. A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.
Abraham R; Basser RL; Green MD
Drug Saf; 1996 Dec; 15(6):406-29. PubMed ID: 8968695
[TBL] [Abstract][Full Text] [Related]
7. Update in cancer chemotherapy: genitourinary tract cancer, Part 6: Cancer of the uterus and vulva.
Wright JC
J Natl Med Assoc; 1988 Jun; 80(6):657-67. PubMed ID: 3292776
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
9. Adriamycin in advanced urinary tract cancer: experience in 42 patients and review of the literature.
Yagoda A; Watson RC; Whitmore WF; Grabstald H; Middleman MP; Krakoff IH
Cancer; 1977 Jan; 39(1):279-85. PubMed ID: 318913
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer.
Horton J; Begg CB; Arseneault J; Bruckner H; Creech R; Hahn RG
Cancer Treat Rep; 1978 Jan; 62(1):159-61. PubMed ID: 626996
[No Abstract] [Full Text] [Related]
11. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Gershenson DM; Copeland LJ
Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinoma.
Muggia FM; Chia G; Reed LJ; Romney SL
Am J Obstet Gynecol; 1977 Jun; 128(3):314-9. PubMed ID: 860739
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.
Wallace HJ; Hreshchyshyn MM; Wilbanks GD; Boronow RC; Fowler WC; Blessing JA
Cancer Treat Rep; 1978 Oct; 62(10):1435-41. PubMed ID: 709549
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
